|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,596.95 INR | -0.16% |
|
-1.91% | +5.10% |
| Aug. 03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| Aug. 03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 440B 4.61B 4B 3.74B 3.41B 6.43B 6.53B 43.88B 17.19B 220B 17.32B 16.94B 735B | P/E 2027 * |
37.9x | P/E 2028 * | 32.9x |
|---|---|---|---|---|---|
| Enterprise Value | 440B 4.61B 4B 3.74B 3.41B 6.43B 6.53B 43.88B 17.19B 220B 17.32B 16.94B 735B | EV / Sales 2027 * |
10.3x | EV / Sales 2028 * | 9.33x |
| Free-Float |
-
| Yield 2027 * |
1.14% | Yield 2028 * | 1.14% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -0.16% | ||
| 1 week | -2.27% | ||
| Current month | -2.13% | ||
| 1 month | +6.63% | ||
| 3 months | +4.52% | ||
| 6 months | -0.87% | ||
| Current year | +5.10% |
| 1 week | 2,508.5 |  | 2,645 |
| 1 month | 2,408.75 | | 2,684.6 |
| Current year | 2,088 | | 2,715.15 |
| 1 year | 2,088 | | 2,899.9 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 2022-11-30 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 2026-03-31 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 2019-03-31 |
| Director/Board Member | 59 | 2020-05-17 | |
Manu Anand
BRD | Director/Board Member | 67 | 2022-05-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.16% | -2.27% | -1.95% | +81.34% | 4.62B | |
| -1.37% | +8.35% | +94.20% | +133.06% | 1,098B | |
| -0.77% | +2.12% | +49.89% | +50.90% | 631B | |
| +0.85% | +2.04% | +26.28% | +65.14% | 438B | |
| -1.13% | +3.62% | +49.72% | +38.22% | 368B | |
| -0.74% | +1.09% | +33.81% | +38.95% | 298B | |
| -1.22% | +2.99% | +8.44% | +6.11% | 251B | |
| -0.70% | +9.35% | +43.74% | +58.09% | 226B | |
| +0.34% | +1.62% | -4.91% | -50.77% | 209B | |
| +2.04% | +3.52% | +13.70% | +69.71% | 165B | |
| Average | -0.01% | +1,751.24% | +31.29% | +49.07% | 368.9B | |
| Weighted average by Cap. | +0.09% | +1,333.08% | +50.97% | +67.32% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.53B 446M 386M 362M 330M 621M 632M 4.24B 1.66B 21.29B 1.67B 1.64B 71.02B | 47.17B 495M 429M 401M 366M 689M 700M 4.7B 1.84B 23.61B 1.86B 1.82B 78.76B |
| Net income | 11.61B 122M 105M 98.76M 90.11M 170M 172M 1.16B 454M 5.81B 457M 447M 19.39B | 13.36B 140M 121M 114M 104M 195M 198M 1.33B 522M 6.69B 526M 515M 22.32B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | ₹2,596.95 | -0.16% | 2,882 |
| 26-08-10 | ₹2,601.00 | +0.31% | 889 |
| 26-08-07 | ₹2,593.05 | +0.52% | 4,070 |
| 26-08-06 | ₹2,579.60 | +0.51% | 1,288 |
| 26-08-05 | ₹2,566.55 | -3.06% | 4,678 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
